Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or ?lot? of Intravenous Immunoglobulin. Scope of the Report: This report focuses on the Intravenous Immunoglobulin (IVIg) in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Baxter Grifols CSL Octapharma Biotest Kedrion Hualan Bio CNBG Shanghai RAAS CBPO LFB Group BPL Sichuan Yuanda Shuyang Market Segment by Countries, covering Germany UK France Russia Italy Market Segment by Type, covers IVIg Liquid IVIg Powder Market Segment by Applications, can be divided into Immunodeficiency Autoimmune Disease Acute Infection There are 17 Chapters to deeply display the Europe Intravenous Immunoglobulin (IVIg) market. Chapter 1, to describe Intravenous Immunoglobulin (IVIg) Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Intravenous Immunoglobulin (IVIg), with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Intravenous Immunoglobulin (IVIg), for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications; Chapter 12, Intravenous Immunoglobulin (IVIg) market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Intravenous Immunoglobulin (IVIg) Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Intravenous Immunoglobulin (IVIg) Introduction 1.2 Market Analysis by Type 1.2.1 IVIg Liquid 1.2.2 IVIg Powder 1.3 Market Analysis by Applications 1.3.1 Immunodeficiency 1.3.2 Autoimmune Disease 1.3.3 Acute Infection 1.4 Market Analysis by Countries 1.4.1 Germany Status and Prospect (
